Glumetza
Depomed pulls diabetes drug Glumetza
June 21, 2010Manufacturing and Production Depomed, Glumetza, manufacturing compliance
Another pharmaceutical manufacturer has been forced to recall products because of contamination caused by a chemical used to treat wooden …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
